open access

Online first
Short communication
Published online: 2022-04-27
Get Citation

The relationship between anisocytosis, quantitative and qualitative characteristics of coronary atherosclerosis, and major adverse cardiac events in patients with coronary artery disease — rationale and study design

Anna Oleksiak1, Cezary Kępka2, Mariusz Kruk2
DOI: 10.33963/KP.a2022.0111
·
Pubmed: 35475462
Affiliations
  1. Department of Intensive Cardiac Therapy, National Institute of Cardiology, Warszawa, Poland
  2. Department of Coronary and Structural Heart Diseases, National Institute of Cardiology, Warszawa, Poland

open access

Online first
Short communication
Published online: 2022-04-27

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

The relationship between anisocytosis, quantitative and qualitative characteristics of coronary atherosclerosis, and major adverse cardiac events in patients with coronary artery disease — rationale and study design

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Short communication

Published online

2022-04-27

Page views

21

Article views/downloads

17

DOI

10.33963/KP.a2022.0111

Pubmed

35475462

Authors

Anna Oleksiak
Cezary Kępka
Mariusz Kruk

References (12)
  1. Oleksiak A, Kruk M, et al. Biomarkers for risk stratification in secondary cardiovascular prevention. A role of red blood cell distribution width and calcium score . Atherosclerosis. 2016; 246: 57–62.
  2. Tonelli M, Sacks F, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008; 117(2): 163–168.
  3. Gul M, Uyarel H, et al. The relationship between red blood cell distribution width and the clinical outcomes in non-ST elevation myocardial infarction and unstable angina pectoris: a 3-year follow-up. Coron Artery Dis. 2012; 23(5): 330–336.
  4. Dabbah S, Hammerman H, et al. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol. 2010; 105(3): 312–317.
  5. Fatemi O, Paranilam J, Rainow A, et al. Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention. J Thromb Thrombolysis. 2013; 35(1): 57–64.
  6. Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007; 50(1): 40–47.
  7. Allen LA, Felker GM, Mehra MR, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail. 2010; 16(3): 230–238.
  8. Zhang Y, Wang Y, et al. Differences in the predictive value of red cell distribution width for the mortality of patients with heart failure due to various heart diseases. J Geriatr Cardiol. 2015; 12(6): 647–654.
  9. Förhécz Z, Gombos T, Borgulya G, et al. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009; 158(4): 659–666.
  10. Rostoff P, Siniarski A, Haberka M, et al. Relationship among the leptin-to-adiponectin ratio, systemic inflammation, and anisocytosis in well-controlled type 2 diabetic patients with atherosclerotic cardiovascular disease. Kardiol Pol. 2020; 78(5): 420–428.
  11. Veeranna V, Zalawadiya SK, et al. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multiethnic population: findings from the 1999-2004 NHANES. Int J Cardiol. 2013; 168(6): 5156–5161.
  12. Lappegård J, Ellingsen TS, Vik A, et al. Red cell distribution width and carotid atherosclerosis progression. The Tromsø Study. Thromb Haemost. 2015; 113(3): 649–654.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl